
TY  - JOUR
TI  - Abstracts
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidemiol Drug Saf
VL  - 24
IS  - S1
SN  - 1053-8569
UR  - https://doi.org/10.1002/pds.3838
DO  - doi:10.1002/pds.3838
SP  - 1
EP  - 587
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts of the 2011 Joanna Briggs Institute International Convention
JO  - International Journal of Evidence-Based Healthcare
VL  - 9
IS  - 3
SN  - 1744-1595
UR  - https://doi.org/10.1111/j.1744-1609.2011.00182.x
DO  - doi:10.1111/j.1744-1609.2011.00182.x
SP  - 282
EP  - 334
PY  - 2011
ER  - 

TY  - JOUR
AU  - Corona, Giovanni
AU  - Goulis, Dimitrios G.
AU  - Huhtaniemi, Ilpo
AU  - Zitzmann, Michael
AU  - Toppari, Jorma
AU  - Forti, Gianni
AU  - Vanderschueren, Dirk
AU  - Wu, Frederick C.
TI  - European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males
JO  - Andrology
JA  - Andrologia
VL  - n/a
IS  - n/a
SN  - 2047-2919
UR  - https://doi.org/10.1111/andr.12770
DO  - doi:10.1111/andr.12770
KW  - cardiovascular risk
KW  - erectile dysfunction
KW  - functional hypogonadism
KW  - libido
KW  - late-onset hypogonadism
KW  - obesity
KW  - testosterone
AB  - Abstract Background Evidence regarding functional hypogonadism, previously referred to as ?late-onset? hypogonadism (LOH), has increased substantially during the last 10 year. Objective To update the European Academy of Andrology (EAA) guidelines on functional hypogonadism. Methods Expert group of Academicians appointed by the EAA generated a series of consensus recommendations according to the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) system. Results The diagnosis of functional hypogonadism should be based on both the presence of clinical symptoms supported by repeatedly low morning fasting serum total testosterone (T) measured with a well-validated assay, after exclusion of organic causes of hypogonadism. Lifestyle changes and weight reduction should be the first approach in all overweight and obese men. Whenever possible, withdrawal/modification of drugs potentially interfering with T production should be advised. Testosterone Replacement Therapy (TRT) is contra-indicated in men with untreated prostate or breast cancer, as well as severe heart failure. Severe low urinary tract symptoms and haematocrit >48-50% represent relative contraindications for TRT. Prostate specific antigen (PSA) and digital rectal examination (DRE) of the prostate should be undertaken in men>40 years of age before initiating TRT to exclude occult prostate cancer. Transdermal T should be preferred for initiation of TRT whereas gonadotrophin therapy is only recommended when fertility is desired in men with secondary hypogonadism. TRT is able to improve sexual function in hypogonadal men. Other potential positive outcomes of TRT remain uncertain and controversial. Conclusion TRT can reliably improve global sexual function in men with hypogonadism in the short term. Long-term clinical benefits, and safety of TRT in functional hypogonadism, remain to be fully documented. Clinicians should therefore explicitly discuss the uncertainties and benefits of TRT and engage them in shared management decision-making.
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidemiol Drug Saf
VL  - 22
IS  - s1
SN  - 1053-8569
UR  - https://doi.org/10.1002/pds.3512
DO  - doi:10.1002/pds.3512
SP  - 1
EP  - 521
PY  - 2013
ER  - 

TY  - JOUR
TI  - 2016 ASPHO ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 63
IS  - S1
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.25998
DO  - doi:10.1002/pbc.25998
SP  - S7
EP  - S103
PY  - 2016
ER  - 

TY  - JOUR
TI  - The Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S5
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7299
DO  - doi:10.1002/bjs.7299
SP  - 1
EP  - 58
PY  - 2010
AB  - Abstract The Annual Scientific Meeting of the Association of Upper Gastrointestinal Surgeons for Great Britain and Ireland takes place this year in Oxford on the 9th and 10th of September. Copyright ? 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Abstracts from the American College of Clinical Pharmacy 2016 Virtual Poster Symposium
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 36
IS  - 7
SN  - 0277-0008
UR  - https://doi.org/10.1002/phar.1782
DO  - doi:10.1002/phar.1782
SP  - e83
EP  - e138
PY  - 2016
ER  - 

TY  - JOUR
TI  - Swiss Society of Surgery
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 101
IS  - s5
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.9542
DO  - doi:10.1002/bjs.9542
SP  - 1
EP  - 25
PY  - 2014
ER  - 

TY  - JOUR
C7  - e27713
TI  - 2019 ASPHO ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 66
IS  - S2
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.27713
DO  - doi:10.1002/pbc.27713
SP  - e27713
PY  - 2019
ER  - 

TY  - JOUR
TI  - Contributed Poster Presentations
JO  - Value in Health
VL  - 10
IS  - 3
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2007.00197_2.x
DO  - doi:10.1111/j.1524-4733.2007.00197_2.x
SP  - A22
EP  - A194
PY  - 2007
ER  - 

TY  - JOUR
TI  - PODIUM SESSIONS
JO  - The Journal of Sexual Medicine
VL  - 7
IS  - s6
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2010.02103_1.x
DO  - doi:10.1111/j.1743-6109.2010.02103_1.x
SP  - 375
EP  - 394
PY  - 2010
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S2
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7050
DO  - doi:10.1002/bjs.7050
SP  - 1
EP  - 75
PY  - 2010
ER  - 

TY  - JOUR
TI  - HIGHLIGHTED POSTERS
JO  - The Journal of Sexual Medicine
VL  - 7
IS  - s6
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2010.02103_2.x
DO  - doi:10.1111/j.1743-6109.2010.02103_2.x
SP  - 395
EP  - 402
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts and Index of Authors
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 25
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1592/phco.2005.25.10.1431
DO  - doi:10.1592/phco.2005.25.10.1431
SP  - 1431
EP  - 1551
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Anaesthesia
JA  - Anaesthesia
VL  - 69
IS  - s3
SN  - 0003-2409
UR  - https://doi.org/10.1111/anae.12766
DO  - doi:10.1111/anae.12766
SP  - 13
EP  - 133
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral and Poster Presentations
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 125
IS  - S3
SN  - 1470-0328
UR  - https://doi.org/10.1111/1471-0528.15493
DO  - doi:10.1111/1471-0528.15493
SP  - 4
EP  - 80
PY  - 2018
ER  - 

TY  - JOUR
TI  - POSTER PRESENTATIONS
JO  - The Journal of Sexual Medicine
VL  - 7
IS  - s6
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2010.02103_3.x
DO  - doi:10.1111/j.1743-6109.2010.02103_3.x
SP  - 403
EP  - 464
PY  - 2010
ER  - 

TY  - JOUR
TI  - Contributed Podium Presentations
JO  - Value in Health
VL  - 10
IS  - 3
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2007.00197_1.x
DO  - doi:10.1111/j.1524-4733.2007.00197_1.x
SP  - A1
EP  - A21
PY  - 2007
ER  - 

TY  - JOUR
TI  - HEALTH CARE DECISIONS USING OUTCOMES RESEARCH CASE STUDY PRESENTATIONSâ€¨CASE STUDY PODIUM PRESENTATIONS
JO  - Value in Health
VL  - 10
IS  - 3
SN  - 1098-3015
UR  - https://doi.org/10.1111/j.1524-4733.2007.00197_3.x
DO  - doi:10.1111/j.1524-4733.2007.00197_3.x
SP  - A197
EP  - A207
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - s1
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2005.0300f.x
DO  - doi:10.1111/j.1538-7836.2005.0300f.x
SP  - SOA01
EP  - SOA36
PY  - 2005
ER  - 
